The novel BET inhibitor UM-002 reduces glioblastoma cell proliferation and invasion
Abstract Bromodomain and extraterminal domain (BET) proteins have emerged as therapeutic targets in multiple cancers, including the most common primary adult brain tumor glioblastoma (GBM). Although several BET inhibitors have entered clinical trials, few are brain penetrant. We have generated UM-00...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/42bc0a0c7a934a7485fd2a2ac6e81440 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|